Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Im­muno­log­i­cal Medicines for Fox­es and Rac­coon Dogs

Immunological veterinary medicinal products, including vaccines, are authorised for foxes.

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Fuch­so­ral

Toll­wut

Ce­va Tierge­sund­heit GmbH

479a/91 04.03.1992 wildlebende Füchse

RABADROP

Toll­wut

Biove­ta, a.s., Tschechien

PEI.V.11977.01.1 18.07.2019 wildlebende Füchse, Marderhund

Ra­bi­gen SAG2

Toll­wut

Vir­bac S.A., Frankre­ich

EU/2/00/021/001 10.04.2000 wildlebende Füchse

EPAR: Ra­bi­gen

Ra­bitec

Toll­wut

CE­VA San­té An­i­male

EU/2/17/219/001-003 01.12.2017 wildlebende Füchse, Marderhund

EPAR: Ra­bitec

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 514 in BAnz AT 01.03.2024 B8.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 04.03.2024